Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Carrier Screening Market, by Type
1.4.2 LAMEA Carrier Screening Market, by Technology
1.4.3 LAMEA Carrier Screening Market, by End User
1.4.4 LAMEA Carrier Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2017, Jun – 2021, Jun) Leading Players
Chapter 4. LAMEA Carrier Screening Market by Type
4.1 LAMEA Expanded Carrier Screening Market by Country
4.2 LAMEA Targeted Disease Carrier Screening Market by Country
Chapter 5. LAMEA Carrier Screening Market by Technology
5.1 LAMEA DNA Sequencing Market by Country
5.2 LAMEA Microarrays Market by Country
5.3 LAMEA Polymerase Chain Reaction Market by Country
5.4 LAMEA Other Technologies Market by Country
Chapter 6. LAMEA Carrier Screening Market by End user
6.1 LAMEA Hospital and Clinics Market by Country
6.2 LAMEA Physician Offices Market by Country
6.3 LAMEA Reference Laboratories Market by Country
6.4 LAMEA Other End user Market by Country
Chapter 7. LAMEA Carrier Screening Market by Country
7.1 Brazil Carrier Screening Market
7.1.1 Brazil Carrier Screening Market by Type
7.1.2 Brazil Carrier Screening Market by Technology
7.1.3 Brazil Carrier Screening Market by End user
7.2 Argentina Carrier Screening Market
7.2.1 Argentina Carrier Screening Market by Type
7.2.2 Argentina Carrier Screening Market by Technology
7.2.3 Argentina Carrier Screening Market by End user
7.3 UAE Carrier Screening Market
7.3.1 UAE Carrier Screening Market by Type
7.3.2 UAE Carrier Screening Market by Technology
7.3.3 UAE Carrier Screening Market by End user
7.4 Saudi Arabia Carrier Screening Market
7.4.1 Saudi Arabia Carrier Screening Market by Type
7.4.2 Saudi Arabia Carrier Screening Market by Technology
7.4.3 Saudi Arabia Carrier Screening Market by End user
7.5 South Africa Carrier Screening Market
7.5.1 South Africa Carrier Screening Market by Type
7.5.2 South Africa Carrier Screening Market by Technology
7.5.3 South Africa Carrier Screening Market by End user
7.6 Nigeria Carrier Screening Market
7.6.1 Nigeria Carrier Screening Market by Type
7.6.2 Nigeria Carrier Screening Market by Technology
7.6.3 Nigeria Carrier Screening Market by End user
7.7 Rest of LAMEA Carrier Screening Market
7.7.1 Rest of LAMEA Carrier Screening Market by Type
7.7.2 Rest of LAMEA Carrier Screening Market by Technology
7.7.3 Rest of LAMEA Carrier Screening Market by End user
Chapter 8. Company Profiles
8.1 Quest Diagnostics, Incorporated
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Recent strategies and developments:
8.1.2.1 Partnerships, Collaborations, and Agreements:
8.1.2.2 Product Launches and Product Expansions:
8.1.2.3 Acquisition and Mergers:
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 Illumina, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Eurofins Scientific Group
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.4.4.2 Acquisition and Mergers:
8.5 Invitae Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.5.2 Acquisition and Mergers:
8.6 OPKO Health, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.7 Fulgent Genetics
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Sema4 OpCo, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Myriad Genetics, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Product Launches and Product Expansions:
8.1 Natera Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
Unique Offerings 